Drugs and Devices

FDA issues proposed guidelines for developing drugs for Alzheimer’s disease

On Feb. 7, 2013, the U.S. Food and Drug Administration (FDA) issued a proposal designed to help companies developing new treatments for patients in the early stages of Alzheimer’s disease. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares